Digging into the math of a study attacking the safety of the abortion pill
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 minutes ago
- Yahoo
Cosmo Announces Launch of Winlevi(R) for Treatment of Acne in Singapore and Malaysia
Dublin, Ireland--(Newsfile Corp. - July 17, 2025) - Cosmo Pharmaceuticals N.V. (SIX: COPN), a global leader in AI-driven healthcare and specialty pharmaceuticals, is pleased to announce the launch of Winlevi® (clascoterone) cream 1% in Singapore and Malaysia, marking its first entry into Southeast Asia through the partnership with Hyphens Pharma International Limited ('Hyphens Pharma'). Winlevi® is a topical treatment for acne vulgaris in patients aged twelve years and older, marking a significant milestone in the commitment of both companies to providing innovative, patient-focused dermatology solutions. Winlevi® is the first topical acne treatment in over 40 years with a first-in-class mechanism of action. Its active ingredient, clascoterone, is the first commercially available topical androgen receptor inhibitor acting directly in the sebaceous glands with no systemic anti-androgen effects; as such, it can be used safely in both males and females. This approach is believed to help reduce sebum production and intervene early in acne pathogenesis. Two identical Phase III studies demonstrated that clascoterone cream 1%, applied topically twice daily for twelve weeks, was more effective than the application of vehicle cream in achieving the Investigator's Global Assessment (IGA) of success, reducing non-inflammatory lesion count (NILC) and inflammatory lesion count (ILC) in patients with facial acne vulgaris. Clascoterone cream 1% was found to be generally well tolerated. As part of the agreement signed in December 2022, Hyphens Pharma has in-licensed the product from Cosmo Pharmaceuticals for distribution across ten Southeast Asian countries (Singapore, Malaysia, Indonesia, Philippines, Vietnam, Thailand, Brunei, Cambodia, Laos and Myanmar), bringing this innovative therapy first to Singapore and Malaysia markets. Registration in other Southeast Asian markets is currently underway, with a progressive rollout planned across the region in due course. This collaboration underscores the dedication of Cosmo and Hyphens Pharma to expanding its dermatology portfolio and addressing the unmet needs of patients with acne vulgaris, a condition that affects millions of individuals worldwide and can cause both physical discomfort and psychological distress. Giovanni Di Napoli, Chief Executive Officer of Cosmo, commented: 'The launch of Winlevi® in Southeast Asia is an important step in our ongoing global expansion and directly supports our 2030 vision of driving sustainable revenue growth through strategic geographic expansion. Together with Hyphens Pharma, we are bringing a truly differentiated dermatology innovation to a rapidly growing market with increasing demand for advanced acne care. This partnership demonstrates tangible progress in executing our long-term growth strategy and underscores our shared commitment to addressing unmet medical needs while delivering meaningful impact for patients across Asia.' Lim See Wah (林世华), Executive Chairman and CEO of Hyphens Pharma, added: 'We're proud to be the first to introduce Winlevi® to Southeast Asia. Acne affects millions in the region, yet for decades, patients have had limited treatment options. This launch marks a significant advancement in acne care, our dermatology portfolio and partnership with Cosmo. We appreciate their trust in us to bring this transformative treatment to the region. Acne isn't just skin-deep – it can impact psychosocial well-being. By expanding access to Winlevi®, we aim to support doctors in their practice and empower patients to manage acne with greater confidence, improving their quality of life.' Acne vulgaris is one of the most common skin conditions, impacting more than 90% of the world's population at some point in their lives. It can have both physical and emotional consequences, affecting individuals' self-esteem and mental health. About Hyphens Pharma International Limited Hyphens Pharma International Limited and its subsidiaries (the "Group") is Singapore's leading specialty pharmaceutical and consumer healthcare group, leveraging its diverse footprint in ASEAN countries. The Group has a direct presence in Singapore, Vietnam, Malaysia, Indonesia and the Philippines, and is supplemented by a marketing and distribution network covering 15 other markets – Bangladesh, Brunei, Cambodia, Hong Kong S.A.R., Macau S.A.R., Myanmar, South Korea, Sri Lanka, Thailand and Gulf Cooperation Council countries, including Bahrain, Kuwait, Oman, Qatar, Saudi Arabia and United Arab Emirates. The Group is headquartered in Singapore, where its strategic planning, finance, regulatory affairs, research and development, legal, business development and logistics operations are based. The Group's core business comprises the following segments: Specialty Pharma Principals, Proprietary Brands, and Medical Hypermart & Digital. Besides marketing and selling a range of specialty pharmaceutical products in selected ASEAN countries through exclusive distributorship or licensing and supply agreements with brand principals mainly from Europe and the United States, the Group also develops, markets and sells its own proprietary range of dermatological products and health supplement products. In addition, the Group operates a medical hypermart for healthcare professionals, healthcare institutions and retail pharmacies, to supply pharmaceutical products and medical supplies and an online pharmacy for doctors to prescribe and have medications delivered to their patients' homes. For more information, visit About Cosmo Cosmo is a life sciences company focused on MedTech AI, dermatology, gastrointestinal diseases, and contract development and manufacturing (CDMO). We design, develop, and manufacture advanced solutions that address critical medical needs and raise the standard of care. Our technologies are trusted by leading global pharmaceutical and MedTech companies and reach patients and healthcare providers around the world. Guided by our purpose - Building Health Confidence - our mission is to empower patients, healthcare professionals, and partners by innovating at the intersection of science and technology. Founded in 1997, Cosmo is headquartered in Dublin, Ireland, with offices in San Diego (USA), and in Lainate, Rome, and Catania (Italy). For more information, visit Financial calendar Half-Year 2025 Results and Report H.C. Wainwright 27th Annual Global Investment Conference, New York City, USA Jefferies Global Healthcare Conference, London, United Kingdom ODDO BHF Forum, Lyon, France July 23, 2025 September 8-10, 2025 November 17-20, 2025 January 8-9, 2026 For further information, please contact: Attachments PDF - English To view the source version of this press release, please visit Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Fox News
6 minutes ago
- Fox News
Meet The Parents
AOC brings a communist pirate home to meet the parents, and now the entire house is divided. Learn more about your ad choices. Visit FOX News Radio
Associated Press
6 minutes ago
- Associated Press
FITNESS PROJECT Becomes One of the First Gyms in the North Houston Metro Area to Launch A Physician-Led Wellness Program
FITNESS PROJECT launches physician-led wellness with ApexMD, bringing Dr. Jim Bowen's expertise to gym members for holistic, personalized care. 'FITNESS PROJECT has always been more than treadmills and dumbbells—our purpose is to build stronger bodies, stronger communities, and stronger purpose.'— Troy Wise, VP of Marketing HUMBLE, TX, UNITED STATES, July 17, 2025 / / -- FITNESS PROJECT, the mission-driven, five-location gym brand serving Greater Houston, is redefining what a community gym can be by introducing a physician-led wellness program in partnership with ApexMD, a top-tier telehealth provider focused on personalized, lifestyle-driven care. Overseen by renowned Mayo Clinic–trained physician Dr. Jim Bowen, M.D.—former Chief of Medical Staff at the U.S. Naval Academy and leader of globally recognized performance and longevity centers such as Tony Robbins' Fountain Life—this collaboration delivers medical-grade wellness services directly inside the fitness environment. Launching as FITNESS PROJECT approaches its five-year anniversary since evolving from Gold's Gym in September 2020, the program underscores the brand's commitment to pairing world-class fitness with accessible, science-backed wellness for every member. 'FITNESS PROJECT has always been more than treadmills and dumbbells—our purpose is to build stronger bodies, stronger communities, and stronger purpose,' said Troy Wise, VP of Marketing. 'As we celebrate five years under the FITNESS PROJECT banner, we're raising the bar again. By blending our vibrant group & studio classes, recovery amenities, and community-focused initiatives with Dr. Bowen's cutting-edge medical protocols, we're giving North Houston a holistic health experience that's affordable, approachable, and truly transformative.' Bryan Murphy, CEO & Founder, added, 'After 25 years in the industry, my vision keeps expanding. Evolving from Gold's Gym to FITNESS PROJECT in 2020 was just the beginning—we're committed to making meaningful wellness accessible to everyone we serve.' - Highlights of the new Fitness Project Medical Wellness Program include: - Private telehealth consultations with licensed ApexMD providers - Personalized health-optimization plans engineered by Dr. Bowen - Physician-prescribed, FDA-approved medications targeting cardiovascular health, visceral-fat reduction, metabolic balance, and improved sleep - Lifestyle coaching aligned with each member's long-term wellness goals and FITNESS PROJECT training programs This Medical Wellness Program is offered to FITNESS PROJECT members separately from standard gym membership, giving participants individualized care in a streamlined, budget-friendly format—whether they're jump-starting healthy habits, boosting vitality, or optimizing athletic performance. To learn more, visit or contact the nearest Fitness Project location in the north Houston area. About Fitness Project: FITNESS PROJECT is a purpose-driven gym brand dedicated to turning personal fitness into community transformation with multiple locations throughout the Greater Houston area, including The Woodlands, Conroe, Kingwood, Magnolia, and Humble, Texas. More than just a place to work out, FITNESS PROJECT is committed to building stronger bodies, stronger communities, and a stronger sense of purpose by offering state-of-the-art facilities, expert-led group & studio fitness classes, personal training, and wellness programs. A portion of every membership supports local charitable initiatives, allowing members to not only improve their own health but also give back. At FITNESS PROJECT, every workout contributes to something bigger—turning personal fitness into community transformation. Learn more at About ApexMD: ApexMD is a leading telemedicine provider focused on delivering personalized, physician-led wellness solutions through secure, accessible virtual care. Founded by Randall Hunt, ApexMD offers comprehensive medical services including weight management, men's health optimization, and longevity protocols. With a mission to bridge the gap between medicine and everyday wellness, ApexMD empowers individuals to achieve optimal health through evidence-based, clinically guided programs. For more information, visit Troy Wise FITNESS PROJECT +1 504-615-6336 email us here Visit us on social media: LinkedIn Instagram Facebook YouTube Legal Disclaimer: EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
